公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1990 | EDRF-release and Ca++-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis,in rat thoracic aorta | Teng C.-M.; Yu S.-M.; Chen C.-C.; Huang Y.-L.; TUR-FU HUANG | Life Sciences | 121 | 116 | |
1995 | Effect of DC-015, a novel potent and selective alpha 1 -adrenoceptor antagonist, comparison with prazosin on noradrenaline-induced platelet aggregation | Yen M.-H.; Lee Y.-M.; TUR-FU HUANG ; Sheu J.-R. | Chinese Journal of Physiology | 0 | 0 | |
1994 | Effect of naloxone on platelet aggregation in rats | Sheu J.-R.; TUR-FU HUANG ; Lee Y.-M.; Yen M.-H. | Chinese Journal of Physiology | 1 | 0 | |
1984 | Effect of the purified phospholipases A2 from snake and bee venoms on rabbit platelet function | Ouyang C.; TUR-FU HUANG | Toxicon | 44 | 43 | |
1994 | Effect on human platelet aggregation of phospholipase A2 purified from Heloderma horridum (beaded lizard) venom | TUR-FU HUANG ; Chiang H.-S. | Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism | 30 | 26 | |
2004 | Effects of a snake venom metalloproteinase, triflamp, on platelet aggregation, platelet-neutrophil and neutrophil-neutrophil interactions: Involvement of platelet GPlbalpha and neutrophil PSGL-I | Tseng Y.-L.; Lee C.-J.; TUR-FU HUANG | Thrombosis and Haemostasis | 20 | 18 | |
1989 | Effects of venom proteases on peptide chromogenic substrates and bovine prothrombin | Teng C.-M.; Wang J.-P.; TUR-FU HUANG ; Liau M.-Y. | Toxicon | 13 | 14 | |
2005 | (-)-Epigallocatechin-3-gallate, a polyphenolic compound from green tea, inhibits fibroblast adhesion and migration through multiple mechanisms | Hung C.-F.; TUR-FU HUANG ; Chiang H.-S.; Wu W.-B. | Journal of Cellular Biochemistry | 44 | 40 | |
1994 | Ex?vivo and In?vivo Antithrombotic Effect of Triflavin, an RGD?containing Peptide | Sheu J.R.; TUR-FU HUANG | Journal of Pharmacy and Pharmacology | 15 | 14 | |
2019 | Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2 | Sung P.-S.; TUR-FU HUANG ; Hsieh S.-L. | Nature Communications | 141 | 134 | |
2008 | FcγRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2 | TUR-FU HUANG ; Chang C.-H.; Ho P.-L.; Chung C.-H. | Experimental Hematology | 8 | 8 | |
1993 | Frangulin B, an antagonist of collagen-induced platelet aggregation and adhesion, isolated from Rhamnus formosana | Teng C.-M.; Lin C.-H.; Lin C.-N.; Chung M.-I.; TUR-FU HUANG | Thrombosis and Haemostasis | 13 | 14 | |
2019 | From discovery of snake venom disintegrins to a safer therapeutic antithrombotic agent | Kuo Y.-J.; Chung C.-H.; TUR-FU HUANG | Toxins | 22 | 18 | |
1992 | HA-29: An inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets | Lin C.-H.; Kuo S.-C.; Huang L.-J.; TUR-FU HUANG ; Teng C.-M. | Thrombosis Research | 3 | 4 | |
1992 | Haemodynamic effects of dicentrine, a novel alpha1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar?Kyoto rats | Yu S.M.; Hsu S.Y.; Ko F.N.; Chen C.C.; Huang Y.L.; TUR-FU HUANG ; Teng C.M. | British Journal of Pharmacology | 39 | 37 | |
1991 | Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist | TUR-FU HUANG ; Chao-Zong L.; Chaoho O.; Che-Ming T. | Biochemical Pharmacology | 64 | 67 | |
2008 | The highly specific platelet glycoprotein (GP) VI agonist trowaglerix impaired collagen-induced platelet aggregation ex vivo through matrix metalloproteinase-dependent GPVI shedding | Chang C.-H.; Chung C.-H.; Kuo H.-L.; Hsu C.-C.; TUR-FU HUANG | Journal of Thrombosis and Haemostasis | 24 | 24 | |
2015 | Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis | Chang, Yao-Wen; Hsieh, Pei-Wen; Chang, Yu-Tsui; Lu, Meng-Hong; TUR-FU HUANG ; Chong, Kowit-Yu; Liao, Hsiang-Ruei; Cheng, Ju-Chien; YAO-WEN CHANG | Oncotarget | 74 | 62 | |
2016 | Improved antithrombotic activity and diminished bleeding side effect of a PEGylated alphaiIb beta 3 antagonist, disintegrin | Hsu C.-C.; Chuang W.-J.; Chung C.-H.; Chang C.-H.; Peng H.-C.; TUR-FU HUANG | Thrombosis Research | 6 | 6 | |
2020 | Improved antithrombotic activity and diminished bleeding side effect of a PEGylated alphaIIb beta 3 antagonist, disintegrin | Kuo Y.-J.; Chang Y.T.; Chung C.-H.; Chuang W.-J.; TUR-FU HUANG | Toxins | 9 | 8 | |